Pāriet uz galveno navigāciju Pāriet uz meklēšanu Pāriet uz galveno saturu

Pituitary Adenoma: SSTR2 rs2236750, SSTR5 rs34037914, and AIP rs267606574 Genetic Variants, Serum Levels, and Ki-67 Labeling Index Associations

  • Greta Gedvilaite-Vaicechauskiene
  • , Loresa Kriauciuniene
  • , Arimantas Tamasauskas
  • , Vita Rovite
  • , Ilona Mandrika
  • , Sheng Nan Wu
  • , Chin Wei Huang
  • , Lina Poskiene
  • , Rasa Liutkeviciene*
  • *Šī darba korespondējošais autors
  • Lithuanian University of Health Sciences
  • Latvian Biomedical Research and Study Centre
  • National Cheng Kung University

Zinātniskās darbības rezultāts: Devums žurnālamZinātniskais raksts (žurnālā)koleģiāli recenzēts

1 Atsauce (Scopus)

Kopsavilkums

Background and Objectives: This study explores the complex pathogenesis of pituitary adenomas (PAs), prevalent intracranial tumors in the pituitary gland. Despite their generally benign nature, PAs exhibit a diverse clinical spectrum involving hormone hypersecretion and varying invasiveness, hinting at multifaceted molecular mechanisms and abnormalities in tumorigenesis and gene regulation. Materials and Methods: The investigation focuses on the Ki-67 labeling index, SSTR2 rs2236750, SSTR5 rs34037914, and AIP rs267606574 polymorphisms, alongside serum levels of SSTR2, SSTR5, and AIP, to discern their association with PAs. The Ki-67 labeling index was assessed using immunohistochemical analysis with the monoclonal antibody clone SP6, representing the percentage of tumor cells showing positive staining. Genotyping was performed via real-time polymerase chain reaction, and serum levels were analyzed using ELISA. The study included 128 PA patients and 272 reference group subjects. Results: The results derived from binary logistic regression analysis revealed an intriguing correlation between the SSTR2 rs2236750 AG genotype and approximately a 1.6-fold increased likelihood of PA occurrence. When analyzing SSTR5 rs34037914, statistically significant differences were found between Micro-PA and the reference group (p = 0.022). Additionally, the SSTR5 rs34037914 TT genotype, compared with CC + CT, under the most robust genetic model (selected based on the lowest AIC value), was associated with a 12-fold increased odds of Micro-PA occurrence. However, it is noteworthy that after applying Bonferroni correction, these findings did not retain statistical significance. Conclusions: Consequently, while this study hinted at a potential link between SSTR2 rs2236750 and pituitary adenoma development, as well as a potential link between SSTR5 rs34037914 and Micro-PA development, it underscored the need for further analysis involving a larger cohort to robustly validate these findings.

OriģinālvalodaAngļu
Raksta numurs1252
ŽurnālsMedicina (Lithuania)
Sējums60
Izdevuma numurs8
DOIs
Publikācijas statussPublicēts - aug. 2024
Ārēji publicēts

Nospiedums

Uzziniet vairāk par pētniecības tēmām “Pituitary Adenoma: SSTR2 rs2236750, SSTR5 rs34037914, and AIP rs267606574 Genetic Variants, Serum Levels, and Ki-67 Labeling Index Associations”. Kopā tie veido unikālu nospiedumu.

Citēt šo